Synthesis of LH, FSH, TSH, and CG requires expression of the primate alpha subunit gene at discrete and different times in cytotrophoblasts of the placenta, cells of the hypophyseal placode, and in gonadotropes and thyrotropes of the pituitary. This complex pattern probably involves both activated and restricted expression dictated by combinatorial arrays of regulatory elements and trans-acting factors. Deciphering the critical elements responsible for correct temporal and spatial expression of the human alpha subunit gene represents the major goal of this proposal. Accordingly, we propose the following Specific Aims: 1. Determine the Identity and Interactive Nature of the Elements and Factors that Target Expression of the alpha SubunIt Gene to Placenta. Placenta-specific expression requires the binding of CREB and several additional proteins to a composite enhancer (PSE). While the functional significance of CREB is well established, the Identity and functional role of the other factors remains unclear. We propose that CREB interacts with some of these proteins to define a unique placenta- specific transcriptional complex. Experimental approaches include transfection, cDNA cloning, and functional analysis of chimeric DNA- binding proteins. 2. Define Regulatory Elements Required for GnRH- and Gonadotrope-Specific Expression of the Human alpha Subunit Gene. Our previous transgenic studies indicate that the 1500 bp human alpha subunit promoter targets expression of reporter genes specifically to gonadotropes but not to thyrotropes. This promoter also renders the transgene responsive to GnRH and sex steroids. Gonadotrope-specific expression probably requires interaction between multiple elements located in the promoter-proximal region. Furthermore, as the receptor for GnRH couples to Galpha/q, we postulate that the PI-PLC pathway plays a role in alpha subunit gene expression and gonadotrope proliferation. Approaches include transfection and a refined transgenic strategy that includes targeted over-expression of components of the Galpha/q pathway. 3. Define Requirements for Complete Temporal and Spatial Expression of the Human alpha Subunit Gene. We postulate that thyrotrope-specific expression of the human alpha subunit gene requires a specific interaction between regulatory elements located in the promoter-proximal region and a distal region that resides between -5000 and -1500 bp relative to the start of transcription. We also suspect that interactions between distal and proximal segments of the promoter affect temporal patterns of expression. Testing this hypothesis requires shielding transgenes from integration site effects as well as defining a transcriptional locus that targets expression to both gonadotropes and thyrotropes. This will involve both transfection and transgenic strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK028559-18
Application #
2770351
Study Section
Biochemical Endocrinology Study Section (BCE)
Program Officer
Sato, Sheryl M
Project Start
1980-09-01
Project End
1999-08-31
Budget Start
1998-09-10
Budget End
1999-08-31
Support Year
18
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Salisbury, Travis B; Binder, April K; Grammer, Jean C et al. (2007) Maximal activity of the luteinizing hormone beta-subunit gene requires beta-catenin. Mol Endocrinol 21:963-71
Jorgensen, Joan S; Quirk, Christine C; Nilson, John H (2004) Multiple and overlapping combinatorial codes orchestrate hormonal responsiveness and dictate cell-specific expression of the genes encoding luteinizing hormone. Endocr Rev 25:521-42
Quirk, Christine C; Seachrist, Darcie D; Nilson, John H (2003) Embryonic expression of the luteinizing hormone beta gene appears to be coupled to the transient appearance of p8, a high mobility group-related transcription factor. J Biol Chem 278:1680-5
Mohammad, Helai P; Abbud, Rula A; Parlow, Al F et al. (2003) Targeted overexpression of luteinizing hormone causes ovary-dependent functional adenomas restricted to cells of the Pit-1 lineage. Endocrinology 144:4626-36
Jorgensen, J S; Nilson, J H (2001) AR suppresses transcription of the LHbeta subunit by interacting with steroidogenic factor-1. Mol Endocrinol 15:1505-16
Jorgensen, J S; Nilson, J H (2001) AR suppresses transcription of the alpha glycoprotein hormone subunit gene through protein-protein interactions with cJun and activation transcription factor 2. Mol Endocrinol 15:1496-504
Quirk, C C; Lozada, K L; Keri, R A et al. (2001) A single Pitx1 binding site is essential for activity of the LHbeta promoter in transgenic mice. Mol Endocrinol 15:734-46
Keri, R A; Bachmann, D J; Behrooz, A et al. (2000) An NF-Y binding site is important for basal, but not gonadotropin-releasing hormone-stimulated, expression of the luteinizing hormone beta subunit gene. J Biol Chem 275:13082-8
Abbud, R A; Ameduri, R K; Rao, J S et al. (1999) Chronic hypersecretion of luteinizing hormone in transgenic mice selectively alters responsiveness of the alpha-subunit gene to gonadotropin-releasing hormone and estrogens. Mol Endocrinol 13:1449-59
Budworth, P R; Quinn, P G; Nilson, J H (1997) Multiple characteristics of a pentameric regulatory array endow the human alpha-subunit glycoprotein hormone promoter with trophoblast specificity and maximal activity. Mol Endocrinol 11:1669-80

Showing the most recent 10 out of 24 publications